Nevada
|
000-51379
|
51-0539830
|
(State
of Incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.
14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
9.01
|
Financial
Statements and Exhibits
|
By:
|
/s/
Senshan Yang
|
|
Name:
|
Senshan
Yang
|
|
Title:
|
Chief
Executive Officer
|
Exhibit
Number
|
Description
|
|
99.1
|
Guangzhou
LifeTech Pharmaceuticals Co., Ltd and Guangzhou LifeTech Medicine
Technologies Co., Ltd Combined Financial Statements as of September
30, 2009 and December 31, 2008 and for the year ended December 31,
2008 and for the nine months ended September 30, 2009 and
2008.
|
|
99.2
|
Unaudited Pro Forma Condensed
Combined Financial Information as of September 30, 2009, for the
nine months ended September 30, 2009, and for the year ended December 31,
2008.
|